ALL OTHER UROLOGICAL PRODUCTS
Comprehensive Range for Urinary Tract Disorders, BPH, and Bladder Control
WHO-GMP Certified | Human Use | Global Export-Ready
🔍 Overview
This category includes a wide selection of urology-focused medications used for the treatment of:
-
Benign Prostatic Hyperplasia (BPH)
-
Overactive Bladder (OAB)
-
Urinary Incontinence
-
Bladder Spasms / Neurogenic Bladder
-
Urinary Retention / Nocturia
-
UTIs (Supportive & Adjuvant Therapy)
These drugs support both acute and chronic urological conditions and are available in oral and injectable forms.
💊 PRODUCT CATALOG
| Brand Name | Generic Name | Strength/Form | Indication |
|---|---|---|---|
| VesiCare | Solifenacin Succinate | 5 mg / 10 mg tablet | Overactive bladder |
| Detrusitol | Tolterodine Tartrate | 1 mg / 2 mg tablet | Urge incontinence, bladder overactivity |
| Myrbetriq | Mirabegron | 25 mg / 50 mg tablet | OAB, urinary frequency |
| Toviaz | Fesoterodine Fumarate | 4 mg / 8 mg ER tablet | Urinary urgency |
| Urotone | Bethanechol Chloride | 10 mg / 25 mg tablet | Urinary retention (neurogenic bladder) |
| Emselex | Darifenacin Hydrobromide | 7.5 mg / 15 mg ER tablet | Urge incontinence, OAB |
| Oxytrol Patch | Oxybutynin Transdermal | 3.9 mg/24h patch | OAB in females |
| Dapagliflozin (adjunct) | Dapagliflozin | 5 mg / 10 mg tablet | Adjunct in UTIs, glucose-induced diuresis |
Available Dosage Forms:
-
Oral Tablets (IR / ER)
-
Transdermal Patches
-
Oral Disintegrating Tablets (for elderly)
-
Soft Gel Capsules
-
Customized Blister Packs / Bottles
📑 Regulatory Support:
-
WHO-GMP, COPP, COA
-
CTD Dossiers (Module 1–5)
-
Stability Data – Zone III / IV
-
Private Labeling Options Available
🌍 Global Export Focus:
-
Latin America, Africa, Middle East, CIS, Southeast Asia
-
Hospital supply, Government tenders, Private channel distribution
-
Multilingual packaging support (English, French, Arabic, etc.)